0001209191-21-010708.txt : 20210216 0001209191-21-010708.hdr.sgml : 20210216 20210216161533 ACCESSION NUMBER: 0001209191-21-010708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210211 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siegel Jolie CENTRAL INDEX KEY: 0001768223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39567 FILM NUMBER: 21638616 MAIL ADDRESS: STREET 1: C/O NEON THERAPEUTICS, INC. STREET 2: 40 ERIE ST., SUITE 110 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: C4 Therapeutics, Inc. CENTRAL INDEX KEY: 0001662579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475617627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 231-0700 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-11 0 0001662579 C4 Therapeutics, Inc. CCCC 0001768223 Siegel Jolie C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #200 WATERTOWN MA 02472 0 1 0 0 Chief Legal Officer Stock Option (Right to Buy) 45.54 2021-02-11 4 A 0 84850 0.00 A 2031-02-10 Common Stock 84850 84850 D This option shall vest and become exercisable in 16 equal quarterly installments, with the first installment vesting on May 11, 2021. /s/ Jolie M. Siegel 2021-02-16